Ponce, Kiarrah Jewelrich S.
HRN: 22-64-32 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/24/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/24/2023
03/02/2023
IV
325mg
Q8Hrs
Intestinal Amoebiasis; UTI
Waiting Final Action
Indication: ProphylaxisEmpiricCulture-directed Type of Infection: BloodstreamIntra-abdominal Compliance to guidelines: Non-compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes